The FDA approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in adults with complement 3 glomerulopathy ...
A new study led by Dr. Hilla Chen, Prof. Gilad Segev and Dr. Michal Mazaki-Tovi from the Koret School of Veterinary Medicine ...
He showed pitting oedema. We considered the effect of bevacizumab, which is an anti-VEGF-A drug. In this case, several injections of bevacizumab already caused proteinuria. Bevacizumab may have ...